(i) evaluate the performance of MR-pro-ADM in reflecting the outcome and risk for CAP patients in the emergency department, and (ii) compare the prognostic performance of MR-pro-ADM with that of clinical scores PSI and CURB65.
Legramante, J.m., Mastropasqua, M., Susi, B., Porzio, O., Mazza, M., Agrippino, G.m., et al. (2017). Prognostic performance of MR-proadrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB. PLOS ONE, 12(11), e0187702 [10.1371/journal.pone.0187702].
Prognostic performance of MR-proadrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB
Legramante J. M.
Conceptualization
;Porzio O.Writing – Review & Editing
;D'Agostini C.Data Curation
;Bernardini S.Supervision
;Minieri M.Writing – Review & Editing
2017-11-01
Abstract
(i) evaluate the performance of MR-pro-ADM in reflecting the outcome and risk for CAP patients in the emergency department, and (ii) compare the prognostic performance of MR-pro-ADM with that of clinical scores PSI and CURB65.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Legramante et al PlosOne 2017.pdf
accesso aperto
Licenza:
Non specificato
Dimensione
2.35 MB
Formato
Adobe PDF
|
2.35 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.